Case Studies in Pharmaceutical / Biotech Pricing 2 – Advanced

Author(s)

Faculty: Jack M Mycka, -, Global President & CEO, Medical Marketing Economics LLC (MME), Montclair, NJ, USA Renato Dellamano, PhD, President, MME Europe & ValueVector (Value Added Business Strategies), Milan, Italy

Case studies will be employed to lead participants through the key steps of new product pricing, with focus on the need to thoroughly analyze the business environment and its constraints and opportunities, and the need to closely integrate the pricing, reimbursement, and pharmacoeconomic strategy for the new product with the clinical development and marketing strategies. Practical exercises will allow participants to consolidate the concepts delivered in the “Elements” introductory session and expanded here. Areas covered will include the post-launch issues of reimbursement and pricing maintenance as a part of life-cycle management in a global environment. This course is designed for those with limited experience in the area of pharmaceutical pricing and covers topics within a global context.

Conference/Value in Health Info

2019-05, ISPOR 2019, New Orleans, LA, USA

Code

SC09

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×